(Via Japan Times) Fujifilm, the Japanese photographic imaging technology multinational, is set to acquire a 49% stake in Texas based vaccine  maker Kalon Biotherapeutics LLC. This move will increase Fujifilm’s foothold in the Biopharma industry, which was cemented in 2011, when it formed Fujifilm Diosynth through the acquisition of Diosynth Biopharmaceuticals of North Carolina and the former Avecia Biolgoics based in the UK.

For the full story click here.